Rapid diagnostic approach to PML-RARα-positive acute promyelocytic leukemia

Hematology Journal

Volumn 3, Issue 5, 2002, Pages 259-263

  Schoch, Claudia ^a   Schnittger, Susanne ^a   Kern, Wolfgang ^a   Lengfelder, Eva ^a   Löffler, Helmut ^a   Hiddemann, Wolfgang ^a   Haferlach, Torsten ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute promyelocytic leukemia; Cryptic rearrangement; Cytogenetics; Fluorescence in situ hybridization; PML RAR rearrangement; Polymerase chain reaction

Indexed keywords

ANTHRACYCLINE; BCR ABL PROTEIN; CYTARABINE; HYBRID PROTEIN; RETINOIC ACID; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CELL STRUCTURE; CHROMOSOME 15; CHROMOSOME 15Q; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE INSERTION; GENE LOCUS; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PHILADELPHIA 1 CHROMOSOME; PROMYELOCYTIC LEUKEMIA; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; GENETICS; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME BANDING; CYTOGENETIC ANALYSIS; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036430359     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200181     Document Type: Article

References (41)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 163: 620-625.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. A variant form of hypergranular promyelocytic leukaemia. (M3). Br J Haematol 1980; 44: 169-170.
4. Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1977; 1: 549-550.
5. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARA with a novel putative transcription factor, PML. Cell 1991; 66: 663-674.
6. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T et al. Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol 1992; 82: 529-540.
7. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, Lo Coco F, Diverio D et al. RAR-α gene rearrangements as a genetic marker for the diagnosis and monitoring in acute promyelocytic leukemia. Blood 1991; 77: 1418-1422.
8. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 1021-1028.
9. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized study. Blood 1993; 82: 3241-3249.
10. Kanamura A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995; 85: 1202-1206.
11. Frankel SR, Eardley A, Heller G, Berman E, Miller WH, Dmitrowsky E et al. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Ann Intern Med 1994; 120: 278-286.
12. Warrell RP, Maslak P, Eardley A, Heller G, Miller WH, Frankel SR. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 1994; 8: 929-933.
13. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P et al. All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remission in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 1992; 80: 2176-2181.
14. Lengfelder E, Reichert A, Schoch C, Haase D, Haferlach T, Löffler H et al. Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. Leukemia 2000; 14: 1362-1370.
15. Löffler H, Rastetter J. Atlas of clinical hematology. 5th edn. Springer: Berlin; 1999.
16. Fonatsch C, Schaadt M, Kirchner H, Diehl V. A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma, lines. Int J Cancer 1980; 26: 749-756.
17. Mitelman F. (ed). ISCN Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature. S Karger: Basel, Switzerland, 1995.
18. Evans P, Jack A, Short M, Haynes A, Shiach C, Owen R et al. A single tube nested RT-PCR for detecting the common myeloid specific chromosomal translocations. Leukemia 1995; 9: 1285-1286.
19. Grimwade D, Biondi A, Mozziconacci M-J, Hagemeijer A, Berger R, Neat M et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17) results of the European Working Party. Blood 2000; 96: 1297-1308.
20. Arnould C, Philippe C, Bourdon V, Grégoire MJ, Berger R, Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic receptor a in acute promyelocytic-like leukemia. Hum Mol Genet 1999; 8: 1741-1749.
21. Sainty D, Liso V, Cantu-Rajnoldi A, Head D, Mozziconacci M-J, Arnoulet C et al. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood 2000; 96: 1287-1296.
22. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR et al. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). Leukemia 2000; 14: 1197-1200.
23. Lo Coco F, Diverio D, D'Adamo F, Avvisati G, Alimena G, Nanni M et al. PML/RAR-alpha rearrangement in acute promyelocytic leukaemias apparently lacking the t(15;17) translocation. Eur J Haematol 1992; 48: 173-176.
24. Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJS, Catovsky D. Interstitial Insertion of retinoic acid receptor-α gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 1994; 83: 2946-2951.
25. Lazaridou A, Chase A, Melo J, Garicochea B, Diamond J, Goldmann J. Lack of reciprocal translocation in BCR-ABL positive Ph-negative chronic myeloid leukaemia. Leukemia 1994; 8: 454-457.
26. Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 1997; 90: 4876-4885.
27. Yamamoto K, Hamaguchi H, Kobayashi M, Tsurukubo Y, Nagata K. Terminal deletion of the long arm of chromosome 9 in acute promyelocytic leukemia with cryptic PML/RAR alpha rearrangement. Cancer Genet Cytogenet 1999; 113: 120-125.
28. Virchis A, Massey E, Butler T, Devaraj P, Wright F, Secker-Walker L et al. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3. Br J Haematol 2001; 114: 551-556.
29. Aventin A, Mateau R, Martino R, Colomer D, Bordes R. A case of cryptic acute promyelocytic leukemia. Leukemia 1998; 12: 1490-1491.
30. Wan TS, Ma SK, Yip SF, Yeung YM, Chan LC. Molecular characterization of der(15)t(11;15) as a secondary cytogenetic abnormality in acute promyelocytic leukemia with cryptic PML-RAR alpha fusion on 17q. Cancer Genet Cytogenet 2000; 121: 90-93.
31. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J et al. Acute promyelocytic leukemia cases with nonreciprocal PML-RARα or RARα/PML fusion genes. Blood 1995; 85: 1169-1174.
32. Brunel V, Lafage-Pochitaloff M, Alcalay M, Pelicci PG, Birg F. Variant and masked translocations in acute promyelocytic leukemia. Leuk Lymphoma 1996; 22: 221-228.
33. Heim S, Mitelman F. Chronic myeloid leukemia. In: Cancer Cytogenetics. 2nd edn. Wiley-Liss: New York; 1995; pp 33-68.
34. Allford S, Grimwade D, Langabeer S, Duprez E, Saurin A, Chatters S et al. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AML. Br J Haematol 1999; 105: 198-207.
35. Langabeer S, Grimwade D, Walker H, Rogers JR, Burnett A, Goldstone A et al. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFβ/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council. Br J Haematol 1998; 101: 338-340.
36. Dyck JA, Warrell RP, Evans RM, Miller WHJ. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein. Blood 1995; 86: 862-867.
37. Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R et al. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunohistochemical evidence for the high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 1995; 85: 1871-1880.
38. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukemia: Cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. Br J Haematol 1996; 94: 557-573.
39. Lo Coco F, Diverio D, Falini B, Biondi A, Nervi C, Pelicci PG. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999; 94: 12-22.
40. Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F et al. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML-RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. Blood 1998; 92: 784-789.
41. Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliana EM et al. Therapy of molecular relapse in acute promyelocytic leukemia. Blood 1999; 94: 2225-2229.